Esperion Therapeutics ESPR Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's change in inventories?
- Esperion Therapeutics (ESPR) reported change in inventories of -$915K in Q1 2026.
- How has Esperion Therapeutics's change in inventories changed year-over-year?
- Esperion Therapeutics's change in inventories decreased by 118.9% year-over-year, from $4.83M to -$915K.
- What is the long-term trend for Esperion Therapeutics's change in inventories?
- Over 2 years (2021 to 2023), Esperion Therapeutics's change in inventories has grown at a 29.1% compound annual growth rate (CAGR), from $18.26M to $30.42M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.